PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17507800-6	2007	The chemosensitivity of C666-1 cells to bleomycin and cisplatin was enhanced by siRNA targeting LMP1.	Bleomycin	40-49	PDZ and LIM domain 7	Homo sapiens	96-100	
17507800-8	2007	Also, cotransfection of constitutive active AKT plasmid with LMP-1 siRNA plasmid abrogates sensitivity of C666-1 to bleomycin and cisplatin.	Bleomycin	116-125	PDZ and LIM domain 7	Homo sapiens	61-66	
12796376-8	2003	For the 303 patients treated with doxorubicin, bleomycin, vinblastine, and dacarbazine or equivalent regimens, the 5-year failure-free survival (FFS) for those with LMP-1-positive tumors was 74% compared with 81% for those with LMP-1-negative tumors (P = 0.23, by log-rank test).	Bleomycin	47-56	PDZ and LIM domain 7	Homo sapiens	165-170	
14716302-5	2004	The expression of wild-type LMP1 enhanced both spontaneous and bleomycin-induced MN formation.	Bleomycin	63-72	PDZ and LIM domain 7	Homo sapiens	28-32	
14716302-10	2004	In this study, H1299 cells harboring LMP1 were shown to be more sensitive to UV and bleomycin than those with a vector control.	Bleomycin	84-93	PDZ and LIM domain 7	Homo sapiens	37-41